Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer

INTRODUCTION: Current prostate cancer (PCa) guidelines primarily focus on localized or metastatic PCa. A multidisciplinary genitourinary oncology panel determined that additional guidance focusing on monitoring and management of biochemical recurrence (BCR) following radical therapy and non-metastat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can Urol Assoc J
Autors principals: Danielson, Brita, Saad, Fred, So, Alan, Morgan, Scott, Hamilton, Robert J., Malone, Shawn, Park-Wyllie, Laura, Zardan, Anousheh, Shayegan, Bobby
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6892682/
https://ncbi.nlm.nih.gov/pubmed/31364976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5600
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars